• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Articles
  • Resources
  • Contact

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome, Fibromyalgia, and IC Disease

  • Home
  • Fibromyalgia
    • Fibromyalgia Awareness
    • Fibromyalgia Research
    • Fibromyalgia Symptoms
    • Fibromyalgia Treatments
  • Chronic Fatigue
    • Awareness
    • Pediatric CFS
    • Research
    • Symptoms
    • Treatments
  • Chronic Illnesses
    • Cancer
    • Interstitial Cystitis
    • Irritable Bowel Syndrome
    • Chronic Pain
    • Vitamin D Deficiency
    • Women’s Health
  • Sandy’s Journey
  • Coping Corner
    • Disability
You are here: Home / Fibromyalgia / Fibromyalgia Treatments / Fibromyalgia Treatment Drug Approved by FDA Expected

Fibromyalgia Treatment Drug Approved by FDA Expected

2 Comments

The first FDA Fibromyalgia treatment drug is to be approved by 2008. The pharmaceutical industry is racing to try and gain approval since prescription drugs for Fibromyalgia is an untapped market.

The report appeared in Reuters News and it stated, “The contenders are looking to seize on a market now dominated by older anti-depressants as well as painkillers and other drugs. The competitors are big pharmaceutical giants like Pfizer, Eli Lilly and Forest Laboratories, Inc.

These competitors are anxiously racing to be the first to win the FDA clearance to market their Fibromyalgia treatment drugs. The research predicts that this market could reach $1 billion in less than 10 years.

There are FDA approved drugs that were created for other illnesses, but are used to treat Fibromyalgia. But the drug companies cannot market drugs specifically for Fibromyalgia until they receive clearance from the FDA.

Some of the drug contenders up for approval include:

Pfizers pregabalin (Lyrica)

This is a FDA approved drug that is used to treat nerve pain and seizures. You can read more about the clinical trial process of this drug by clicking here.

Eli Lillys duloxetine (Cymbalta)

Duloxetine is a drug approved as an anti-depressant that regulates two brain transmitters, serotonin and norepinephrine. You can read more about clinical trials on this drug by clicking here.

Forest Laboratories Milnacipran

Another serotonin/norepinephrine regulating drug that like duloxetine has been approved as an anti-depressant and is now completing Phase III FM pain trials is Forest Laboratories Milnacipran. You can read more information about this drug by clicking here.

Filed Under: Fibromyalgia Treatments Tagged With: Cymbalta, Fibromyalgia, Lyrica

Reader Interactions

Comments

  1. colleen says

    June 21, 2007 at 1:11 am

    Thank God!!! I had to fight with this demon for three years!!! Mine just went away after years of exercise and doctors telling me I was crazy Im so
    glad they are coming out with meds to help people!!

    Reply
  2. stevejohnson says

    November 3, 2008 at 3:41 am

    These competitors are anxiously racing to be the first to win the FDA clearance to market their Fibromyalgia treatment drugs. The research predicts that this market could reach $1 billion in less than 10 years.
    =========================
    steve
    Drug Rehab

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

find us on facebook

Recent Comments

  • Kris on The Dangers of Vitamin D Deficiency
  • Rocco on Aspartame Side Effects – Is there a link?
  • jodan on Dr. Oz On ME/CFS & XMRV
  • john thomson on CFS & Fibromyalgia Symptoms Flare In Cold Weather
  • Alison on Latest Problem: Inner Ear Issues
  • Beth on CFS, FM and MS Share Similar Symptoms…But Are Not the Same
  • Grace on Are There Effects of Tattooing on ME/CFS & Fibromyalgia Patients?

Secondary Sidebar

Sub Topics

  • Fibromyalgia Awareness
  • Fibromyalgia Research
  • Fibromyalgia Symptoms
  • Fibromyalgia Treatments

Copyright © 2021 ยท FightingFatigue.org